Accueil>>Signaling Pathways>> Proteases>> HSP>>ML-346

ML-346

Catalog No.GC18170

ML-346 est un activateur de l'expression de Hsp70 et de l'activité HSF-1, avec une EC50 de 4,6 μM pour Hsp70. ML-346 restaure le repliement des protéines dans des modèles de maladies conformationnelles, sans cytotoxicité significative ni manque de spécificité. Le ML-346 induit des augmentations spécifiques des gènes et des effecteurs protéiques de la réponse au choc thermique (HSR), y compris des chaperons tels que Hsp70, Hsp40 et Hsp27.

Products are for research use only. Not for human use. We do not sell to patients.

ML-346 Chemical Structure

Cas No.: 100872-83-1

Taille Prix Stock Qté
10mM 1 mL in DMSO
63,00 $US
En stock
2mg
42,00 $US
En stock
5mg
69,00 $US
En stock
10mg
110,00 $US
En stock
50mg
331,00 $US
En stock
100mg
529,00 $US
En stock
500mg
1 322,00 $US
En stock
1g
1 983,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

ML-346 is an activator of the heat shock response that induces the expression of the heat shock proteins HSP70, HSP40, and HSP27.[1] It induces the expression of the oxidative stress response genes HO1, GCLM, and BiP in mouse embryonic fibroblasts (MEFs) and pretreatment protects cells from severe heat shock-induced death and H2O2-induced apoptosis. It promotes folding of metastable proteins in models of conformational disease, including cellular models of Huntingtin aggregation and cystic fibrosis. It reduces aggregate formation in PC12 cells expressing human Huntingtin exon 1 containing a 74 glutamine expansion when used at a concentration of 10 uM. It also corrects trafficking of cystic fibrosis transmembrane conductance regulator proteins bearing the F508 deletion (F508-CFTR) mutation carried by the majority of cystic fibrosis patients, leading to increased cell surface expression.

References
[1]. Calamini, B., Silva, M.C., Madoux, F., et al. Small-molecule proteostasis regulators for protein conformational diseases. Nat. Chem. Biol. 8(2), 185-196 (2011).

Avis

Review for ML-346

Average Rating: 5 ★★★★★ (Based on Reviews and 21 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for ML-346

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.